v3.26.1
Revenue and Segment Information - Summary of Significant Segment Expenses (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
Total revenue $ 173,933 $ 143,537
Total cost of revenue 72,772 55,309
Research, development and clinical trials:    
Research, development and clinical trials 24,879 17,160
Selling, general and administrative:    
Selling, general and administrative 62,985 43,625
Other segment items [1] 5,982 1,761
Net income 7,315 25,682
Cost of net product revenue    
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
Total revenue 107,972 88,234
Total cost of revenue 24,308 16,312
Cost of service revenue    
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
Total revenue 65,961 55,303
Total cost of revenue 48,464 38,997
Personnel related (including stock-based compensation expense)    
Research, development and clinical trials:    
Research, development and clinical trials 8,408 6,252
Selling, general and administrative:    
Selling, general and administrative 34,106 27,671
Laboratory supplies and research materials    
Research, development and clinical trials:    
Research, development and clinical trials 4,141 4,956
Consulting and third-party services    
Research, development and clinical trials:    
Research, development and clinical trials 8,409 4,173
Clinical trials costs    
Research, development and clinical trials:    
Research, development and clinical trials 705 81
Professional and consultant fees    
Selling, general and administrative:    
Selling, general and administrative 9,262 7,558
NOP support    
Selling, general and administrative:    
Selling, general and administrative 1,580 2,406
Tradeshows and conferences    
Selling, general and administrative:    
Selling, general and administrative 1,269 426
Facility and IT related and other    
Research, development and clinical trials:    
Research, development and clinical trials 3,216 1,698
Selling, general and administrative:    
Selling, general and administrative 7,792 4,322
Depreciation and amortization expense    
Selling, general and administrative:    
Selling, general and administrative 6,062 $ 1,242
Transaction-related costs    
Selling, general and administrative:    
Selling, general and administrative 2,707  
Headquarters relocation costs    
Selling, general and administrative:    
Selling, general and administrative $ 207  
[1] Other segment items include interest income, interest expense, foreign currency exchange gains and losses and income taxes. See the condensed consolidated financial statements for other financial information regarding the Company’s operating segment.